DENTSPLY SIRONA Inc.(XRAY)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,132 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
XRAY Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for DENTSPLY SIRONA Inc. (XRAY), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores XRAY at 39.8/100 on a 32-signal composite quality model, placing it at rank #2,132 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (15.8) and balance sheet strength (17.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), DENTSPLY SIRONA Inc. reports quarterly revenue of $898.0M, net income of $37.0M, free cash flow of $55.0M. Top institutional holders of XRAY by reported 13-F value include BlackRock, FULLER & THALER ASSET MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. XRAY trades on the Nasdaq exchange and files with the SEC under CIK 818479. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate XRAY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DENTSPLY SIRONA Inc. directly from SEC EDGAR. DENTSPLY SIRONA Inc.'s 13F Pro composite quality score has ranged between 29 and 57 since 2021, currently 39.8 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$898.0M
Net Income
Q2 2026
$37.0M
Free Cash Flow
Q2 2026
$55.0M
ROIC
Q2 2026
9.2%
D/E Ratio
Q2 2026
1.65
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-3.0% YoYNet Income
+34.3% YoYOperating Income
+52.0% YoYEPS (Diluted)
+33.0% YoYTotal Assets
-5.6% YoYTotal Debt
+16.2% YoYOp. Cash Flow
-49.0% YoYFree Cash Flow
-63.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.68B -3.0% | $3.79B -4.3% | $3.96B +1.1% | $3.92B -7.3% | $4.23B +26.7% | $3.34B |
| Net Income | $-598.0M +34.3% | $-910.0M -589.4% | $-132.0M +86.1% | $-950.0M -331.1% | $411.0M +663.0% | $-73.0M |
| Operating Income | $-422.0M +52.0% | $-879.0M -934.1% | $-85.0M +90.9% | $-937.0M -254.1% | $608.0M +20366.7% | $-3.0M |
| EPS (Diluted) | $-3.00 +33.0% | $-4.48 -622.6% | $-0.62 +85.9% | $-4.41 -335.8% | $1.87 +666.7% | $-0.33 |
| Total Assets | $5.43B -5.6% | $5.75B -21.9% | $7.37B -3.6% | $7.64B -17.3% | $9.24B -1.2% | $9.35B |
| Total Debt | $2.82B +16.2% | $2.42B +5.1% | $2.31B +16.0% | $1.99B -5.5% | $2.10B -26.9% | $2.88B |
| Operating Cash Flow | $235.0M -49.0% | $461.0M +22.3% | $377.0M -27.1% | $517.0M -21.3% | $657.0M +1.2% | $649.0M |
| Free Cash Flow | $104.0M -63.0% | $281.0M +23.2% | $228.0M -38.0% | $368.0M -28.5% | $515.0M -8.4% | $562.0M |
Get alerted when XRAY's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for DENTSPLY SIRONA Inc. including:
Top Institutional Holders of XRAY
BlackRock, Inc.
$283.4M26,711,079 shFULLER & THALER ASSET MANAGEMENT, INC.
$134.7M12,697,269 shVANGUARD PORTFOLIO MANAGEMENT LLC
$125.0M11,779,851 shAQR CAPITAL MANAGEMENT LLC
$110.2M10,458,771 shSTATE STREET CORP
$98.5M9,285,298 shVANGUARD CAPITAL MANAGEMENT LLC
$96.0M9,047,628 shLAZARD ASSET MANAGEMENT LLC
$87.7M8,269,867 shARIEL INVESTMENTS, LLC
$85.2M8,026,107 shSouthpoint Capital Advisors LP
$74.3M7,000,000 shCOOKE & BIELER LP
$73.5M6,927,915 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $283.4M | 26,711,079 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $134.7M | 12,697,269 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $125.0M | 11,779,851 |
| AQR CAPITAL MANAGEMENT LLC | $110.2M | 10,458,771 |
| STATE STREET CORP | $98.5M | 9,285,298 |
| VANGUARD CAPITAL MANAGEMENT LLC | $96.0M | 9,047,628 |
| LAZARD ASSET MANAGEMENT LLC | $87.7M | 8,269,867 |
| ARIEL INVESTMENTS, LLC | $85.2M | 8,026,107 |
| Southpoint Capital Advisors LP | $74.3M | 7,000,000 |
| COOKE & BIELER LP | $73.5M | 6,927,915 |
Companies Similar to XRAY
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
PERRIGO Co plc
Chemours Co
OLIN Corp
Brookdale Senior Living Inc.
Enovis CORP
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Viatris Inc
QuidelOrtho Corp
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put XRAY on your watchlist
Track score changes the day DENTSPLY SIRONA Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is XRAY a good stock to buy?
13F Pro's AI-powered analysis of DENTSPLY SIRONA Inc. (XRAY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for XRAY are available on the XRAY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. XRAY is classified as a mid company.
Which hedge funds own XRAY?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling XRAY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DENTSPLY SIRONA Inc.'s investment landscape.